Menglin Wang

机构：Beijing Tongren Hospital, China West Normal University, Capital Medical University, Precision Therapeutics (United States), Beijing Municipal Education Commission · ORCID：0000-0001-6240-6856

发表论文 65 篇 · 总被引 380 次 · h-index 10

代表论文

• Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial (2025 · Nature Medicine · 被引 42)
• Fe3O4@SiO2@MPA-TAPA-COF as a novel sorbent in magnetic solid-phase extraction coupling with UPLC-MS/MS for determining 12 sulfonamides in water and milk (2024 · Microchemical Journal · 被引 19)
• Saikosaponin A alleviates depressive-like behavior induced by reserpine in mice by regulating gut microflora and inflammatory responses (2025 · PLoS ONE · 被引 12)
• Trends and Clinical Features of Pet Sensitization of Allergic Rhinitis from 2017 to 2023 in Beijing, China (2025 · International Archives of Allergy and Immunology · 被引 4)
• Stapokibart (CM310) in patients with uncontrolled seasonal allergic rhinitis (PHECDA): Rationale and design of a multicentre, randomized, double-blind, placebo-controlled study (2025 · Asia Pacific Allergy · 被引 4)
• New Cretaceous Fossil Achilidae Taxa (Insecta, Hemiptera, Fulgoromorpha) from Burmese Ambers with Description of Niryasaburniini Trib. Nov. (2024 · Insects · 被引 3)